查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1869627

坐骨神经痛治疗市场规模、份额和趋势分析报告：按产品、给药途径、分销管道、地区和细分市场预测（2025-2033 年）

Sciatica Treatment Market Size, Share & Trends Analysis Report By Product, By Route of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

坐骨神经痛治疗市场摘要

2024年全球坐骨神经痛治疗市场规模估计为51.5亿美元，预计2033年将达到107.1亿美元。

预计从 2025 年到 2033 年，其复合年增长率将达到 8.40%。这一增长归因于几个关键因素，包括全球坐骨神经痛盛行率的上升、人口老化以及治疗方法的进步。

由于医疗保健、患者照护和技术进步等领域的广泛趋势，坐骨神经痛治疗市场正经历显着增长。其中一个关键驱动因素是全球人口老化。随着人们寿命的延长，坐骨神经痛等肌肉骨骼疾病的发生率也增加。世界卫生组织（世卫组织）根据2024年10月的估计，到2030年，全球六分之一的人口将达到或超过60岁。届时，60岁及以上人口的比例将从2020年的10亿增加到14亿。预计到2050年，全球老年人口将翻倍（达21亿）。预计2020年至2050年间，80岁及以上人口的数量将增加两倍，达到4.26亿，这将导致坐骨神经痛等慢性疾病的显着增加。这一年龄层尤其容易罹患坐骨神经痛等慢性疾病。

随着老年人口的增长，对有效治疗方法坐骨神经痛相关慢性疼痛和行动障碍的需求也日益增长。这一趋势在北美和欧洲等老龄化人口集中的地区尤为明显。美国疾病管制与预防中心（CDC）已将肌肉骨骼疾病（MSD）列为美国成年人残疾的主要原因之一。这些疾病包括背痛、关节损伤、肌腱炎和重复性劳损。它们可能导致暂时性或永久性残疾，限制部分患者的行动能力。职业性肌肉骨骼疾病在劳动年龄人口中尤其普遍，这进一步加剧了对坐骨神经痛治疗的需求。因此，这些地区的医疗保健系统正致力于开发和提供老年患者的专业治疗方法，从而推动了市场扩张。

此外，干细胞疗法和富血小板血浆（PRP）注射等生物治疗方法的发展，为更有针对性、更有效的坐骨神经痛治疗提供了可能，尤其适用于椎间盘退化和神经损伤的病例。鑑于目前对PRP在慢性下背痛等疾病中潜在益处的研究不断深入，这些治疗方法未来完全有可能应用于坐骨神经痛的治疗。同时，梅奥诊所继续提供传统的坐骨神经痛治疗方法，包括物理治疗、药物治疗和硬膜外类固醇注射，这些都是治疗坐骨神经痛的成熟治疗方法。随着新技术的不断涌现，治疗选择将更加多样化，从而为市场成长和创新创造机会。

另一个关键驱动因素是人们对坐骨神经痛及其治疗方案的认识不断提高。随着大众对慢性疼痛和肌肉骨骼疾病的了解不断加深，越来越多的患者开始寻求诊断和治疗坐骨神经痛症状。根据美国疾病管制与预防中心 (CDC) 2023 年美国美国患有慢性疼痛，其中 8.5% 的人患有严重影响日常生活或工作的慢性疼痛。慢性疼痛和严重影响日常生活的慢性疼痛是成年人就医最常见的原因之一。医疗保健提供者也越来越强调早期疗育的重要性，早期介入可以减少长期残疾并改善患者的整体预后。

除了公众意识的提高，人们也越来越重视改善治疗的可近性，尤其是在发展中地区。亚太和拉丁美洲等地区医疗基础设施的扩建，正在促进患者更容易获得传统和现代疗法。例如，2023年3月，世界银行核准了一项用于改善印度医疗基础设施的资金，其中包括扩大脊椎护理服务，预计这将有助于满足该地区日益增长的坐骨神经痛治疗需求。

此外，远端医疗服务和居家照护选择的兴起扩大了治疗的覆盖范围，尤其惠及偏远和医疗资源匮乏地区的病患。这种治疗机会的增加，加上人们对该疾病认识的提高以及治疗方法的进步，为未来几年坐骨神经痛治疗市场的持续扩张奠定了基础。

目录

第一章调查方法和范围

第二章执行摘要

第三章 坐骨神经痛治疗市场变数、趋势与范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业环境分析
    • 产业分析—波特五力分析
    • PESTLE分析
    • 管道分析
    • 专利到期分析
    • 定价分析

第四章 坐骨神经痛治疗市场：依产品分類的商业分析

  • 按产品分類的市场份额，2024 年和 2033 年
  • 产品细分仪表板
  • 2021-2033年按产品分類的市场规模、预测与趋势分析
  • 止痛药和非类固醇抗发炎药
  • 神经病变疼痛药物
  • 皮质类固醇
  • 其他的

第五章 坐骨神经痛治疗市场：依给药途径分類的业务分析

  • 按给药途径分類的市场份额，2024 年和 2033 年
  • 管理路线细分仪表板
  • 按管理途径分類的市场规模、预测和趋势分析，2021-2033年
  • 口服
  • 外用
  • 肠外/注射剂

第六章 坐骨神经痛治疗市场：区域估算与趋势分析

  • 2024 年及 2033 年区域市占率分析
  • 区域市场概览
  • 市场规模及预测趋势分析（2021-2033）：
  • 北美洲
    • 按国家/地区划分，2021-2033 年
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争情势

  • 参与者概览
  • 企业市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
    • Glenmark Pharmaceuticals Ltd.
    • Sorrento Therapeutics Inc.
    • Medtronic plc
    • Boston Scientific Corporation
    • Pfizer Inc.
    • Johnson &Johnson
    • Abbott Laboratories
Product Code: GVR-4-68040-769-7

Sciatica Treatment Market Summary

The global sciatica treatment market size was estimated at USD 5.15 billion in 2024 and is projected to reach USD 10.71 billion by 2033, growing at a CAGR of 8.40% from 2025 to 2033. This growth is attributed to several key factors, including the rising global prevalence of sciatica, aging populations, and advancements in treatment modalities.

The sciatica treatment market is experiencing significant growth, driven by several key factors that reflect broader trends in healthcare, patient care, and technological advancements. One of the primary drivers is the aging global population. As people live longer, the incidence of musculoskeletal conditions like sciatica increases. According to the World Health Organization, October 2024, By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time, the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million, with a significant rise in chronic conditions such as sciatica. This demographic is particularly vulnerable to chronic conditions like sciatica.

As the number of older adults rises, so does the demand for effective treatment options to address the chronic pain and mobility issues associated with sciatica. This trend is especially noticeable in regions like North America and Europe, where a significant proportion of the population is aging. The Centers for Disease Control and Prevention (CDC) has identified musculoskeletal disorders (MSDs) as a leading cause of disability among U.S. adults. These disorders encompass conditions such as back pain, joint injuries, tendinitis, and repetitive strain. They can cause temporary or even permanent disability, leaving some individuals unable to move around easily. Work-related MSDs are particularly prevalent among people during their working years, contributing to a rise in demand for sciatica treatments. Consequently, healthcare systems in these regions are focusing on developing and providing specialized treatment options for older patients, thus contributing to market expansion.

Furthermore, the development of biologic treatments, such as stem cell therapy and platelet-rich plasma (PRP) injections, offers potential for more targeted and effective management of sciatica, especially in cases involving disc degeneration or nerve damage. Given the rise in research on PRP's potential benefits for conditions like chronic lower back pain, it is plausible that treatments like these could be explored for sciatica in the future. In the same period, Mayo Clinic continued to offer more conventional treatments for sciatica, such as physical therapy, medications, and injections (like epidural steroids), which have been well-established as effective for managing sciatica-related pain. As new technologies continue to emerge, treatment options will diversify, creating opportunities for market growth and innovation.

Another important driver is the increasing awareness of sciatica and its available treatment options. As public awareness around chronic pain conditions and musculoskeletal disorders rises, more patients are seeking diagnosis and management for sciatica symptoms. According to the Centers for Disease Control and Prevention (CDC), data from the National Health Interview Survey in 2023 revealed that 24.3% of U.S. adults had chronic pain, and 8.5% had high-impact chronic pain that frequently limited life or work activities. Chronic pain and high-impact chronic pain are among the most common reasons adults seek medical care. Healthcare providers are also increasingly emphasizing early intervention, which helps reduce long-term disability and improves overall patient outcomes.

In addition to growing awareness, there is a greater focus on improving access to treatment, especially in developing regions. The expansion of healthcare infrastructure in regions like Asia Pacific and Latin America is facilitating greater access to both traditional and modern treatment options. For example, in March 2023, the World Bank approved funding to improve healthcare infrastructure in India, including the expansion of spine care services. This is expected to support a greater demand for sciatica treatments in the region.

Furthermore, the increasing availability of telemedicine services and home care options is also allowing for broader access to treatment, particularly for patients in remote or underserved areas. This growing accessibility, combined with higher awareness and advancements in treatment methods, positions the sciatica treatment market for continued expansion in the coming years.

Global Sciatica Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global sciatica treatment market report based on product, route of administration, distribution channel, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Analgesics & NSAIDs
  • Neuropathic Pain Agents
  • Corticosteroids
  • Others
  • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
  • Oral
  • Topical
  • Parenteral / Injectable
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Retail Pharmacy
  • Hospital Pharmacy
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Route of Administration
    • 1.2.3. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Sciatica Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis
    • 3.3.4. Patent Expiry Analysis
    • 3.3.5. Pricing Analysis

Chapter 4. Sciatica Treatment Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2033
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Analgesics & NSAIDs
    • 4.4.1. Analgesics & NSAIDs Market, 2021 - 2033 (USD Million)
  • 4.5. Neuropathic Pain Agents
    • 4.5.1. Neuropathic Pain Agents Market, 2021 - 2033 (USD Million)
  • 4.6. Corticosteroids
    • 4.6.1. Corticosteroids Market, 2021 - 2033 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Sciatica Treatment Market: Route of Administration Business Analysis

  • 5.1. Route of Administration Market Share, 2024 & 2033
  • 5.2. Route of Administration Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Route of Administration, 2021 to 2033 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market, 2021 - 2033 (USD Million)
  • 5.5. Topical
    • 5.5.1. Topical Market, 2021 - 2033 (USD Million)
  • 5.6. Parenteral / Injectable
    • 5.6.1. Parenteral / Injectable Market, 2021 - 2033 (USD Million)

Chapter 6. Sciatica Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.4. North America
    • 6.4.1. North America Sciatica Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Target Disease Prevalence
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Reimbursement Framework
      • 6.4.2.5. U.S. Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Target Disease Prevalence
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Reimbursement Framework
      • 6.4.3.5. U.S. Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Target Disease Prevalence
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Reimbursement Framework
      • 6.4.4.5. Mexico Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Target Disease Prevalence
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement Framework
      • 6.5.2.5. Uk Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Target Disease Prevalence
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement Framework
      • 6.5.3.5. Germany Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Target Disease Prevalence
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Reimbursement Framework
      • 6.5.4.5. France Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Target Disease Prevalence
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Reimbursement Framework
      • 6.5.5.5. Italy Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Target Disease Prevalence
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement Framework
      • 6.5.6.5. Spain Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.7. Denmark
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Target Disease Prevalence
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement Framework
      • 6.5.7.5. Denmark Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.8. Sweden
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Target Disease Prevalence
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement Framework
      • 6.5.8.5. Sweden Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.5.9. Norway
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Target Disease Prevalence
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement Framework
      • 6.5.9.5. Norway Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Target Disease Prevalence
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement Framework
      • 6.6.2.5. Japan Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Target Disease Prevalence
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement Framework
      • 6.6.3.5. China Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Target Disease Prevalence
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement Framework
      • 6.6.4.5. India Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.5. Australia
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Target Disease Prevalence
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement Framework
      • 6.6.5.5. Australia Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.6. South Korea
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Target Disease Prevalence
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement Framework
      • 6.6.6.5. South Korea Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Target Disease Prevalence
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement Framework
      • 6.6.7.5. Thailand Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Target Disease Prevalence
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement Framework
      • 6.7.2.5. Japan Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Target Disease Prevalence
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement Framework
      • 6.7.3.5. China Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Middle East and Africa
    • 6.8.1. Middle East and Africa Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Target Disease Prevalence
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement Framework
      • 6.8.2.5. South Africa Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Target Disease Prevalence
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement Framework
      • 6.8.3.5. Saudi Arabia Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Target Disease Prevalence
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement Framework
      • 6.8.4.5. UAE Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Target Disease Prevalence
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement Framework
      • 6.8.5.5. Kuwait Sciatica Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. AbbVie Inc.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Disease Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Teva Pharmaceutical Industries Ltd.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Disease Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Sun Pharmaceutical Industries Ltd.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Disease Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Glenmark Pharmaceuticals Ltd.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Sorrento Therapeutics Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Medtronic plc
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Boston Scientific Corporation
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Pfizer Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Johnson & Johnson
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Abbott Laboratories
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global sciatica treatment market, by region, 2021 - 2033 (USD Million)
  • Table 4 Global sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 5 Global sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 6 Global sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 7 North America sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 8 North America sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 9 North America sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 10 North America sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 11 US sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 12 US sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 13 Canada sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 14 Canada sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 15 Canada sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 16 Mexico sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 17 Mexico sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 18 Mexico sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 19 Europe sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 20 Europe sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 22 Europe sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 23 UK sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 24 UK sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 25 UK sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 26 Germany sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 27 Germany sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 28 Germany sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 29 France sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 30 France sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 31 France sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 32 Italy sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 33 Italy sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 34 Italy sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 35 Spain sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 36 Spain sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 37 Spain sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 38 Norway sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 39 Norway sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 40 Norway sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 41 Denmark sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 42 Denmark sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 43 Denmark sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 44 Sweden sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 45 Sweden sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 46 Sweden sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 47 Asia Pacific sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 48 Asia Pacific sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 49 Asia Pacific sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 50 Asia Pacific sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 51 Japan sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 52 Japan sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 53 Japan sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 54 China sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 55 China sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 56 China sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 57 India sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 58 India sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 59 India sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 60 Australia sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 61 Australia sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 62 Australia sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 63 South Korea sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 64 South Korea sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 65 South Korea sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 66 Thailand sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 67 Thailand sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 68 Thailand sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 69 Latin America sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 70 Latin America sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 71 Latin America sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 72 Latin America sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 73 Brazil sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 74 Brazil sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 75 Brazil sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 76 Argentina sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 77 Argentina sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 78 Argentina sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 79 Middle East & Africa Sciatica treatment market, by country, 2021 - 2033 (USD Million)
  • Table 80 Middle East & Africa sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 81 Middle East & Africa sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 82 Middle East & Africa sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 83 South Africa sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 84 South Africa sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 85 South Africa sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 86 Saudi Arabia sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 87 Saudi Arabia sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 88 Saudi Arabia sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 89 UAE sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 90 UAE sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 91 UAE sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 92 Kuwait sciatica treatment market, by product, 2021 - 2033 (USD Million)
  • Table 93 Kuwait sciatica treatment market, by route of administration, 2021 - 2033 (USD Million)
  • Table 94 Kuwait sciatica treatment market, by distribution channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Sciatica treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Therapeutic approach and product outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Sciatica treatment market dynamics
  • Fig. 12 Sciatica treatment market: Porter's five forces analysis
  • Fig. 13 Sciatica treatment market: PESTLE analysis
  • Fig. 14 Product market, 2021 - 2033 (USD Million)
  • Fig. 15 Analgesics & NSAIDs market, 2021 - 2033 (USD Million)
  • Fig. 16 Neuropathic Pain Agents market, 2021 - 2033 (USD Million)
  • Fig. 17 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Route of Administration market, 2021 - 2033 (USD Million)
  • Fig. 20 Oral market, 2021 - 2033 (USD Million)
  • Fig. 21 Topical market, 2021 - 2033 (USD Million)
  • Fig. 22 Parenteral / Injectable market, 2021 - 2033 (USD Million)
  • Fig. 23 Distribution Channel market, 2021 - 2033 (USD Million)
  • Fig. 24 Retail Pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 25 Hospital Pharmacy market, 2021 - 2033 (USD Million)
  • Fig. 26 Others market, 2021 - 2033 (USD Million)
  • Fig. 27 Sciatica treatment market revenue, by region
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 36 Europe sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 53 Asia Pacific sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 66 Latin America sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 71 MEA sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait sciatica treatment market, 2021 - 2033 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework